{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T08:01:16Z","timestamp":1790755276016,"version":"4.1.0"},"reference-count":23,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,6,2]],"date-time":"2026-06-02T00:00:00Z","timestamp":1780358400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000053","name":"NEI","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000053","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Ophthalmology Retina"],"published-print":{"date-parts":[[2026,10]]},"DOI":"10.1016\/j.oret.2026.05.018","type":"journal-article","created":{"date-parts":[[2026,6,4]],"date-time":"2026-06-04T00:10:28Z","timestamp":1780531828000},"page":"1027-1035","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Gildeuretinol Acetate versus Placebo for Geographic Atrophy Secondary to Age-Related Macular Degeneration"],"prefix":"10.1016","volume":"10","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9219-1614","authenticated-orcid":false,"given":"David S.","family":"Boyer","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leonide","family":"Saad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ilyas","family":"Washington","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexander","family":"Melamud","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0006-9677-9814","authenticated-orcid":false,"given":"Kenneth B.","family":"Graham","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adrian E.","family":"O\u2019Malley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gabrielle M.","family":"DeBartolomeo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0004-4556-3242","authenticated-orcid":false,"given":"Honghua","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lindsey D.","family":"Harris","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christine N.","family":"Kay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1748-4614","authenticated-orcid":false,"given":"Philip J.","family":"Ferrone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seemi","family":"Khan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.oret.2026.05.018_bib1","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1186\/s12877-024-04689-9","article-title":"Perpetuating ability to live life as usual: a grounded theory study of persons living with age-related macular degeneration","volume":"24","author":"K\u00e4llstrand","year":"2024","journal-title":"BMC Geriatr"},{"key":"10.1016\/j.oret.2026.05.018_bib2","first-page":"1063","article-title":"Impact of incident age-related macular degeneration and associated vision loss on vision-related quality of life","volume":"106","author":"Man","year":"2022","journal-title":"Br J Ophthalmol"},{"issue":"10411","key":"10.1016\/j.oret.2026.05.018_bib3","doi-asserted-by":"crossref","first-page":"1449","DOI":"10.1016\/S0140-6736(23)01583-0","article-title":"Efficacy and safety of avacincaptad pegol in patients with geographic atrophy (GATHER2): 12-month results from a randomised, double-masked, phase 3 trial","volume":"402","author":"Khanani","year":"2023","journal-title":"Lancet"},{"issue":"17","key":"10.1016\/j.oret.2026.05.018_bib4","doi-asserted-by":"crossref","first-page":"3551","DOI":"10.1038\/s41433-023-02497-w","article-title":"Avacincaptad pegol for geographic atrophy secondary to age-related macular degeneration: 18-month findings from the GATHER1 trial","volume":"37","author":"Patel","year":"2023","journal-title":"Eye"},{"key":"10.1016\/j.oret.2026.05.018_bib5","doi-asserted-by":"crossref","first-page":"1434","DOI":"10.1016\/S0140-6736(23)01520-9","article-title":"Pegcetacoplan for the treatment of geographic atrophy secondary to age-related macular degeneration (OAKS and DERBY): two multicentre, randomised, double-masked, sham-controlled, phase 3 trials","volume":"402","author":"Heier","year":"2023","journal-title":"Lancet"},{"key":"10.1016\/j.oret.2026.05.018_bib6","doi-asserted-by":"crossref","first-page":"1392","DOI":"10.1167\/iovs.08-2868","article-title":"Complement activation by bisretinoid constituents of RPE lipofuscin","volume":"50","author":"Zhou","year":"2009","journal-title":"Investig Opthalmology Vis Sci"},{"key":"10.1016\/j.oret.2026.05.018_bib7","doi-asserted-by":"crossref","first-page":"7958","DOI":"10.1074\/jbc.M110.178640","article-title":"Deuterium enrichment of vitamin A at the C20 position slows the formation of detrimental vitamin A dimers in wild-type todents","volume":"286","author":"Kaufman","year":"2011","journal-title":"J Biol Chem"},{"key":"10.1016\/j.oret.2026.05.018_bib8","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1167\/tvst.10.14.8","article-title":"C20D 3 -vitamin A prevents retinal pigment epithelium atrophic changes in a mouse model","volume":"10","author":"Zhang","year":"2021","journal-title":"Transl Vis Sci Technol"},{"key":"10.1016\/j.oret.2026.05.018_bib9","doi-asserted-by":"crossref","DOI":"10.1016\/j.jbc.2021.101074","article-title":"Vitamin A cycle byproducts impede dark adaptation","volume":"297","author":"Zhang","year":"2021","journal-title":"J Biol Chem"},{"key":"10.1016\/j.oret.2026.05.018_bib10","doi-asserted-by":"crossref","first-page":"8415","DOI":"10.1073\/pnas.1506960112","article-title":"Rescue of the Stargardt phenotype in Abca4 knockout mice through inhibition of vitamin A dimerization","volume":"112","author":"Charbel Issa","year":"2015","journal-title":"Proc Natl Acad Sci"},{"key":"10.1016\/j.oret.2026.05.018_bib11","doi-asserted-by":"crossref","first-page":"7966","DOI":"10.1074\/jbc.M110.178657","article-title":"C20-D3-vitamin A slows lipofuscin accumulation and electrophysiological retinal degeneration in a mouse model of Stargardt disease","volume":"286","author":"Ma","year":"2011","journal-title":"J Biol Chem"},{"key":"10.1016\/j.oret.2026.05.018_bib12","first-page":"1677","article-title":"The retina rapidly incorporates ingested C20-D3-vitamin A in a swine model","volume":"19","author":"Mihai","year":"2013","journal-title":"Mol Vis"},{"key":"10.1016\/j.oret.2026.05.018_bib13","doi-asserted-by":"crossref","DOI":"10.1016\/j.jval.2016.09.1301","article-title":"Reliability and convergent validity of the NEI VFQ-25 with and without near and distance activity appendix items in patients with geographic atrophy secondary to age-related macular degeneration","volume":"19","author":"Kapre","year":"2016","journal-title":"Value in Health"},{"key":"10.1016\/j.oret.2026.05.018_bib14","doi-asserted-by":"crossref","first-page":"6298","DOI":"10.1167\/iovs.16-20361","article-title":"Functional reading independence (FRI) index: a new patient-reported outcome measure for patients with geographic atrophy","volume":"57","author":"Kimel","year":"2016","journal-title":"Investig Opthalmology Vis Sci"},{"key":"10.1016\/j.oret.2026.05.018_bib15","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1097\/00006324-198404000-00006","article-title":"Effect of luminance, contrast, and eccentricity on visual acuity in senile macular degeneration","volume":"61","author":"Brown","year":"1984","journal-title":"Am J Optom Physiol Opt"},{"key":"10.1016\/j.oret.2026.05.018_bib16","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1111\/opo.12775","article-title":"Low luminance visual acuity as a clinical measure and clinical trial outcome measure: a scoping review","volume":"41","author":"Wood","year":"2021","journal-title":"Ophthalmic Physiol Opt"},{"key":"10.1016\/j.oret.2026.05.018_bib17","doi-asserted-by":"crossref","first-page":"3456","DOI":"10.1167\/iovs.17-22339","article-title":"Report from the NEI\/FDA endpoints workshop on age-related macular degeneration and inherited retinal diseases","volume":"58","author":"Csaky","year":"2017","journal-title":"Investig Ophthalmol Vis Sci"},{"key":"10.1016\/j.oret.2026.05.018_bib18","doi-asserted-by":"crossref","first-page":"1677","DOI":"10.1016\/S0161-6420(97)30079-7","article-title":"Visual function abnormalities and prognosis in eyes with age-related geographic atrophy of the macula and good visual acuity","volume":"104","author":"Sunness","year":"1997","journal-title":"Ophthalmology"},{"key":"10.1016\/j.oret.2026.05.018_bib19","doi-asserted-by":"crossref","first-page":"1804","DOI":"10.1016\/j.ophtha.2007.06.047","article-title":"Visual acuity as an outcome measure in clinical trials of retinal diseases","volume":"114","author":"Beck","year":"2007","journal-title":"Ophthalmology"},{"key":"10.1016\/j.oret.2026.05.018_bib20","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1111\/aos.15794","article-title":"Geographic atrophy - signs, symptoms, and quality of life","volume":"101","author":"Krogh Nielsen","year":"2023","journal-title":"Acta Ophthalmol"},{"key":"10.1016\/j.oret.2026.05.018_bib21","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1167\/tvst.11.5.10","article-title":"The NEI VFQ-25C: calibrating items in the National Eye Institute Visual Function Questionnaire-25 to enable comparison of outcome measures","volume":"11","author":"Goldstein","year":"2022","journal-title":"Transl Vis Sci Technol"},{"key":"10.1016\/j.oret.2026.05.018_bib22","doi-asserted-by":"crossref","first-page":"1207","DOI":"10.1001\/archopht.123.9.1207","article-title":"Responsiveness of the National Eye Institute Visual Function Questionnaire to progression to advanced age-related macular degeneration, vision loss, and lens opacity: AREDS report no. 14","volume":"123","author":"Lindblad","year":"2005","journal-title":"Arch Ophthalmol"},{"key":"10.1016\/j.oret.2026.05.018_bib23","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1016\/j.ajo.2025.05.023","article-title":"Visual acuity and quality of life outcomes with pegcetacoplan treatment: a post hoc analysis from the OAKS and DERBY trials","volume":"277","author":"Chiang","year":"2025","journal-title":"Am J Ophthalmol"}],"container-title":["Ophthalmology Retina"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S246865302600268X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S246865302600268X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T07:41:04Z","timestamp":1790754064000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S246865302600268X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10]]},"references-count":23,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2026,10]]}},"alternative-id":["S246865302600268X"],"URL":"https:\/\/doi.org\/10.1016\/j.oret.2026.05.018","relation":{},"ISSN":["2468-6530"],"issn-type":[{"value":"2468-6530","type":"print"}],"subject":[],"published":{"date-parts":[[2026,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Gildeuretinol Acetate versus Placebo for Geographic Atrophy Secondary to Age-Related Macular Degeneration","name":"articletitle","label":"Article Title"},{"value":"Ophthalmology Retina","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.oret.2026.05.018","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 American Academy of Ophthalmology, Inc. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}